The highest and widespread SOCS2 expression in BM hematopoietic populations was associated with aggressive acute leukemia subsets, namely acute myeloid (AML) and lymphoblastic leukemias (ALL) with MLL rearrangments and BCR/ABL abnormalities. Here, KMT2A is linked to acute myeloid leukemia.